This provider's $22.8M in total Medicare payments ranks in the 96th percentile of Clinical Laboratory providers nationally.
This provider's billing patterns fall within normal ranges for their specialty.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 178% in 2015
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $42.42 | $19.99 | 2.12x | $22.43 | $1.5M | 64.7K | 48.9K |
| 2015 | $54.99 | $26.87 | 2.05x | $28.12 | $4.1M | 175.9K | 84.3K |
| 2016 | $215.09 | $43.42 | 4.95x | $171.67 | $4.2M | 26.2K | 13.8K |
| 2017 | $178.75 | $32.61 | 5.48x | $146.14 | $3.5M | 20.2K | 11.6K |
| 2018 | $139.21 | $54.75 | 2.54x | $84.46 | $2.2M | 12.6K | 5.5K |
| 2019 | $94.56 | $37.84 | 2.50x | $56.72 | $2.3M | 17.2K | 8.9K |
| 2020 | $148.02 | $81.22 | 1.82x | $66.80 | $3.3M | 28.8K | 12.2K |
| 2021 | $179.71 | $77.48 | 2.32x | $102.23 | $1.2M | 13.2K | 4.4K |
| 2022 | $105.64 | $68.41 | 1.54x | $37.23 | $427.6K | 7.3K | 2.2K |
| 2023 | $169.27 | $164.83 | 1.03x | $4.44 | $45.7K | 226 | 180 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| G0483 | Drug test def 22+ classes | 36.6K | $8.4M | $230.63 | 6.13x |
| G0482 | Drug test def 15-21 classes | 20.3K | $3.8M | $188.01 | 3.31x |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 26.4K | $2.4M | $92.68 | 1.08x |
| G0481 | Drug test def 8-14 classes | 5.0K | $713.6K | $142.75 | 3.46x |
| 80307 | Testing for presence of drug | 6.8K | $488.0K | $71.80 | 2.20x |
| G6041 | Alkaloids, urine, quantitative | 10.5K | $420.2K | $39.92 | 2.05x |
| G6046 | Dihydromorphinone | 10.5K | $360.4K | $34.20 | 2.05x |
| G0479 | Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, TOF, MALDI, LDTD, DESI, DART, GHPC, GC mass spectrometry), includes sample validation when | 4.0K | $307.3K | $77.64 | 2.87x |
| G6056 | Opiate(s), drug and metabolites, each procedure | 11.5K | $297.4K | $25.90 | 2.04x |
| G6045 | Dihydrocodeinone | 10.5K | $289.3K | $27.46 | 2.05x |
| G6031 | Benzodiazepines | 11.1K | $271.9K | $24.60 | 2.05x |
| G6055 | Nicotine | 8.0K | $253.1K | $31.52 | 2.04x |
| G6053 | Methadone | 10.7K | $232.6K | $21.73 | 2.04x |
| G6042 | Amphetamine or methamphetamine | 11.0K | $227.0K | $20.68 | 2.05x |
| G6044 | Cocaine or metabolite | 10.5K | $211.5K | $20.16 | 2.05x |
| G6030 | Amitriptyline | 8.5K | $201.7K | $23.81 | 2.05x |
| G6032 | Desipramine | 8.4K | $192.3K | $22.89 | 2.05x |
| G6036 | Assay of imipramine | 8.4K | $192.2K | $22.89 | 2.05x |
| G6058 | Drug confirmation, each procedure | 10.8K | $178.7K | $16.51 | 2.12x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 6.9K | $171.2K | $24.94 | 1.00x |
This provider submits charges 3.72 times higher than what Medicare actually pays.
A markup ratio of 3.72x means for every $100 Medicare pays, this provider initially charges $372. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data